Lucca LE and Hafler DA |
Resisting fatal attraction: a glioma oncometabolite prevents CD8+ T cell recruitment. |
2017 |
J. Clin. Invest. |
pmid:28319049
|
Intlekofer AM et al. |
L-2-Hydroxyglutarate production arises from noncanonical enzyme function at acidic pH. |
2017 |
Nat. Chem. Biol. |
pmid:28263965
|
Chaturvedi A et al. |
Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivo. |
2017 |
Leukemia |
pmid:28232670
|
Ma S et al. |
L2hgdh Deficiency Accumulates l-2-Hydroxyglutarate with Progressive Leukoencephalopathy and Neurodegeneration. |
2017 |
Mol. Cell. Biol. |
pmid:28137912
|
Chen F et al. |
Oncometabolites d- and l-2-Hydroxyglutarate Inhibit the AlkB Family DNA Repair Enzymes under Physiological Conditions. |
2017 |
Chem. Res. Toxicol. |
pmid:28269980
|
Tarhonskaya H et al. |
Studies on the Interaction of the Histone Demethylase KDM5B with Tricarboxylic Acid Cycle Intermediates. |
2017 |
J. Mol. Biol. |
pmid:28827149
|
Obayashi H et al. |
Plasma 2-hydroxyglutarate and hexanoylcarnitine levels are potential biomarkers for skeletal muscle toxicity in male Fischer 344 rats. |
2017 |
J Toxicol Sci |
pmid:28717097
|
Amatangelo MD et al. |
Enasidenib induces acute myeloid leukemia cell differentiation to promote clinical response. |
2017 |
Blood |
pmid:28588019
|
Ansó E et al. |
The mitochondrial respiratory chain is essential for haematopoietic stem cell function. |
2017 |
Nat. Cell Biol. |
pmid:28504706
|
Jiang B et al. |
IDH1 Mutation Promotes Tumorigenesis by Inhibiting JNK Activation and Apoptosis Induced by Serum Starvation. |
2017 |
Cell Rep |
pmid:28402860
|
Kim H et al. |
In-Vivo Proton Magnetic Resonance Spectroscopy of 2-Hydroxyglutarate in Isocitrate Dehydrogenase-Mutated Gliomas: A Technical Review for Neuroradiologists. |
2016 Sep-Oct |
Korean J Radiol |
pmid:27587950
|
Choi C et al. |
Prospective Longitudinal Analysis of 2-Hydroxyglutarate Magnetic Resonance Spectroscopy Identifies Broad Clinical Utility for the Management of Patients With IDH-Mutant Glioma. |
2016 |
J. Clin. Oncol. |
pmid:28248126
|
Burr SP et al. |
Mitochondrial Protein Lipoylation and the 2-Oxoglutarate Dehydrogenase Complex Controls HIF1α Stability in Aerobic Conditions. |
2016 |
Cell Metab. |
pmid:27923773
|
Tyrakis PA et al. |
S-2-hydroxyglutarate regulates CD8+ T-lymphocyte fate. |
2016 |
Nature |
pmid:27798602
|
Nadtochiy SM et al. |
Acidic pH Is a Metabolic Switch for 2-Hydroxyglutarate Generation and Signaling. |
2016 |
J. Biol. Chem. |
pmid:27510037
|
Johannessen TA et al. |
Rapid Conversion of Mutant IDH1 from Driver to Passenger in a Model of Human Gliomagenesis. |
2016 |
Mol. Cancer Res. |
pmid:27430238
|
Kingsbury JM et al. |
Cancer-associated isocitrate dehydrogenase mutations induce mitochondrial DNA instability. |
2016 |
Hum. Mol. Genet. |
pmid:27427385
|
Jafari-Khouzani K et al. |
Volumetric relationship between 2-hydroxyglutarate and FLAIR hyperintensity has potential implications for radiotherapy planning of mutant IDH glioma patients. |
2016 |
Neuro-oncology |
pmid:27382115
|
Fujii T et al. |
Targeting isocitrate dehydrogenase (IDH) in cancer. |
2016 |
Discov Med |
pmid:27355333
|
Ricoult SJ et al. |
Sterol Regulatory Element Binding Protein Regulates the Expression and Metabolic Functions of Wild-Type and Oncogenic IDH1. |
2016 |
Mol. Cell. Biol. |
pmid:27354064
|
Teng X et al. |
Lactate Dehydrogenase C Produces S-2-Hydroxyglutarate in Mouse Testis. |
2016 |
ACS Chem. Biol. |
pmid:27333189
|
Nagashima H et al. |
Diagnostic value of glutamate with 2-hydroxyglutarate in magnetic resonance spectroscopy for IDH1 mutant glioma. |
2016 |
Neuro-oncology |
pmid:27154922
|
Chaturvedi A et al. |
Enantiomer-specific and paracrine leukemogenicity of mutant IDH metabolite 2-hydroxyglutarate. |
2016 |
Leukemia |
pmid:27063596
|
Fiehn O et al. |
Registered report: The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. |
2016 |
Elife |
pmid:26943899
|
Fathi AT et al. |
Elevation of Urinary 2-Hydroxyglutarate in IDH-Mutant Glioma. |
2016 |
Oncologist |
pmid:26834160
|
Heo H et al. |
On the Utility of Short Echo Time (TE) Single Voxel 1H-MRS in Non-Invasive Detection of 2-Hydroxyglutarate (2HG); Challenges and Potential Improvement Illustrated with Animal Models Using MRUI and LCModel. |
2016 |
PLoS ONE |
pmid:26820720
|
Becker-Kettern J et al. |
Saccharomyces cerevisiae Forms D-2-Hydroxyglutarate and Couples Its Degradation to D-Lactate Formation via a Cytosolic Transhydrogenase. |
2016 |
J. Biol. Chem. |
pmid:26774271
|
Flavahan WA et al. |
Insulator dysfunction and oncogene activation in IDH mutant gliomas. |
2016 |
Nature |
pmid:26700815
|
de la Fuente MI et al. |
Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma. |
2016 |
Neuro-oncology |
pmid:26691210
|
Emir UE et al. |
Noninvasive Quantification of 2-Hydroxyglutarate in Human Gliomas with IDH1 and IDH2 Mutations. |
2016 |
Cancer Res. |
pmid:26669865
|
Liesenfeld DB et al. |
Aspirin Reduces Plasma Concentrations of the Oncometabolite 2-Hydroxyglutarate: Results of a Randomized, Double-Blind, Crossover Trial. |
2016 |
Cancer Epidemiol. Biomarkers Prev. |
pmid:26585118
|
Andronesi OC et al. |
Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate. |
2016 |
Clin. Cancer Res. |
pmid:26534967
|
Waitkus MS et al. |
Isocitrate dehydrogenase mutations in gliomas. |
2016 |
Neuro-oncology |
pmid:26188014
|
Wang P et al. |
Oncometabolite D-2-Hydroxyglutarate Inhibits ALKBH DNA Repair Enzymes and Sensitizes IDH Mutant Cells to Alkylating Agents. |
2015 |
Cell Rep |
pmid:26686626
|
Tateishi K et al. |
Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion. |
2015 |
Cancer Cell |
pmid:26678339
|
Churchill H et al. |
Discordant intracellular and plasma D-2-hydroxyglutarate levels in a patient with IDH2 mutated angioimmunoblastic T-cell lymphoma. |
2015 |
Int J Clin Exp Pathol |
pmid:26617922
|
Li F et al. |
NADP(+)-IDH Mutations Promote Hypersuccinylation that Impairs Mitochondria Respiration and Induces Apoptosis Resistance. |
2015 |
Mol. Cell |
pmid:26585387
|
Cheng QY et al. |
Sensitive Determination of Onco-metabolites of D- and L-2-hydroxyglutarate Enantiomers by Chiral Derivatization Combined with Liquid Chromatography/Mass Spectrometry Analysis. |
2015 |
Sci Rep |
pmid:26458332
|
Nadtochiy SM et al. |
Metabolomic profiling of the heart during acute ischemic preconditioning reveals a role for SIRT1 in rapid cardioprotective metabolic adaptation. |
2015 |
J. Mol. Cell. Cardiol. |
pmid:26388263
|
Li L et al. |
Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cells. |
2015 |
PLoS ONE |
pmid:26368816
|
Wu F et al. |
Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds. |
2015 |
J. Med. Chem. |
pmid:26280302
|
Evans B and Griner E |
Registered report: Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. |
2015 |
Elife |
pmid:26231040
|
Intlekofer AM et al. |
Hypoxia Induces Production of L-2-Hydroxyglutarate. |
2015 |
Cell Metab. |
pmid:26212717
|
Oldham WM et al. |
Hypoxia-Mediated Increases in L-2-hydroxyglutarate Coordinate the Metabolic Response to Reductive Stress. |
2015 |
Cell Metab. |
pmid:26212716
|
Tai H and Zhang Z |
A novel compound heterozygous mutation in a Chinese boy with L-2-hydroxyglutaric aciduria: a case study. |
2015 |
BMC Neurol |
pmid:26208971
|
Fu X et al. |
2-Hydroxyglutarate Inhibits ATP Synthase and mTOR Signaling. |
2015 |
Cell Metab. |
pmid:26190651
|
Hwang VJ et al. |
The cpk model of recessive PKD shows glutamine dependence associated with the production of the oncometabolite 2-hydroxyglutarate. |
2015 |
Am. J. Physiol. Renal Physiol. |
pmid:26155843
|
Macaulay RJ |
Impending Impact of Molecular Pathology on Classifying Adult Diffuse Gliomas. |
2015 |
Cancer Control |
pmid:26068765
|
Suijker J et al. |
The oncometabolite D-2-hydroxyglutarate induced by mutant IDH1 or -2 blocks osteoblast differentiation in vitro and in vivo. |
2015 |
Oncotarget |
pmid:26046462
|
Izquierdo-Garcia JL et al. |
IDH1 Mutation Induces Reprogramming of Pyruvate Metabolism. |
2015 |
Cancer Res. |
pmid:26045167
|
Pichumani K et al. |
Conditions for (13)C NMR detection of 2-hydroxyglutarate in tissue extracts from isocitrate dehydrogenase-mutated gliomas. |
2015 |
Anal. Biochem. |
pmid:25908561
|
Lombardi G et al. |
Diagnostic value of plasma and urinary 2-hydroxyglutarate to identify patients with isocitrate dehydrogenase-mutated glioma. |
2015 |
Oncologist |
pmid:25862748
|
Pellegatta S et al. |
Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial glioma. |
2015 |
Acta Neuropathol Commun |
pmid:25849072
|
Ma S et al. |
D-2-hydroxyglutarate is essential for maintaining oncogenic property of mutant IDH-containing cancer cells but dispensable for cell growth. |
2015 |
Oncotarget |
pmid:25825982
|
Oizel K et al. |
D-2-Hydroxyglutarate does not mimic all the IDH mutation effects, in particular the reduced etoposide-triggered apoptosis mediated by an alteration in mitochondrial NADH. |
2015 |
Cell Death Dis |
pmid:25811801
|
Keum YS and Choi BY |
Isocitrate dehydrogenase mutations: new opportunities for translational research. |
2015 |
BMB Rep |
pmid:25787993
|
Shi X et al. |
Functions of idh1 and its mutation in the regulation of developmental hematopoiesis in zebrafish. |
2015 |
Blood |
pmid:25778530
|
Rzem R et al. |
A mouse model of L-2-hydroxyglutaric aciduria, a disorder of metabolite repair. |
2015 |
PLoS ONE |
pmid:25763823
|
Hirata M et al. |
Mutant IDH is sufficient to initiate enchondromatosis in mice. |
2015 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:25730874
|
Charitou P et al. |
FOXOs support the metabolic requirements of normal and tumor cells by promoting IDH1 expression. |
2015 |
EMBO Rep. |
pmid:25648147
|
Chan SM et al. |
Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia. |
2015 |
Nat. Med. |
pmid:25599133
|
Fan J et al. |
Human phosphoglycerate dehydrogenase produces the oncometabolite D-2-hydroxyglutarate. |
2015 |
ACS Chem. Biol. |
pmid:25406093
|
Reitman ZJ et al. |
Genetic dissection of leukemia-associated IDH1 and IDH2 mutants and D-2-hydroxyglutarate in Drosophila. |
2015 |
Blood |
pmid:25398939
|
Patay Z et al. |
Successive distinct high-grade gliomas in L-2-hydroxyglutaric aciduria. |
2015 |
J. Inherit. Metab. Dis. |
pmid:25338511
|
Wen H et al. |
Metabolomic comparison between cells over-expressing isocitrate dehydrogenase 1 and 2 mutants and the effects of an inhibitor on the metabolism. |
2015 |
J. Neurochem. |
pmid:25251602
|
Suijker J et al. |
Inhibition of mutant IDH1 decreases D-2-HG levels without affecting tumorigenic properties of chondrosarcoma cell lines. |
2015 |
Oncotarget |
pmid:25895133
|
Worth AJ et al. |
Rotenone Stereospecifically Increases (S)-2-Hydroxyglutarate in SH-SY5Y Neuronal Cells. |
2015 |
Chem. Res. Toxicol. |
pmid:25800467
|
Deng G et al. |
Selective inhibition of mutant isocitrate dehydrogenase 1 (IDH1) via disruption of a metal binding network by an allosteric small molecule. |
2015 |
J. Biol. Chem. |
pmid:25391653
|
Natsumeda M et al. |
Accumulation of 2-hydroxyglutarate in gliomas correlates with survival: a study by 3.0-tesla magnetic resonance spectroscopy. |
2014 |
Acta Neuropathol Commun |
pmid:25376594
|
Chittaranjan S et al. |
Mutations in CIC and IDH1 cooperatively regulate 2-hydroxyglutarate levels and cell clonogenicity. |
2014 |
Oncotarget |
pmid:25277207
|
Liu Z et al. |
Inhibition of cancer-associated mutant isocitrate dehydrogenases: synthesis, structure-activity relationship, and selective antitumor activity. |
2014 |
J. Med. Chem. |
pmid:25271760
|
Shim EH et al. |
L-2-Hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancer. |
2014 |
Cancer Discov |
pmid:25182153
|
Saha SK et al. |
Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer. |
2014 |
Nature |
pmid:25043045
|
Pope WB |
Intraoperative mass spectrometry of tumor metabolites. |
2014 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:25028494
|
Reitman ZJ et al. |
Cancer-associated isocitrate dehydrogenase 1 (IDH1) R132H mutation and d-2-hydroxyglutarate stimulate glutamine metabolism under hypoxia. |
2014 |
J. Biol. Chem. |
pmid:24986863
|
Santagata S et al. |
Intraoperative mass spectrometry mapping of an onco-metabolite to guide brain tumor surgery. |
2014 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:24982150
|
Kato Kaneko M et al. |
Isocitrate dehydrogenase mutation is frequently observed in giant cell tumor of bone. |
2014 |
Cancer Sci. |
pmid:24898068
|
Fathi AT et al. |
Isocitrate dehydrogenase 1 (IDH1) mutation in breast adenocarcinoma is associated with elevated levels of serum and urine 2-hydroxyglutarate. |
2014 |
Oncologist |
pmid:24760710
|
Elhammali A et al. |
A high-throughput fluorimetric assay for 2-hydroxyglutarate identifies Zaprinast as a glutaminase inhibitor. |
2014 |
Cancer Discov |
pmid:24740997
|
Tarhonskaya H et al. |
Non-enzymatic chemistry enables 2-hydroxyglutarate-mediated activation of 2-oxoglutarate oxygenases. |
2014 |
Nat Commun |
pmid:24594748
|
Akbay EA et al. |
D-2-hydroxyglutarate produced by mutant IDH2 causes cardiomyopathy and neurodegeneration in mice. |
2014 |
Genes Dev. |
pmid:24589777
|
Pusch S et al. |
D-2-Hydroxyglutarate producing neo-enzymatic activity inversely correlates with frequency of the type of isocitrate dehydrogenase 1 mutations found in glioma. |
2014 |
Acta Neuropathol Commun |
pmid:24529257
|
Menendez JA et al. |
Gerometabolites: the pseudohypoxic aging side of cancer oncometabolites. |
2014 |
Cell Cycle |
pmid:24526120
|
Borger DR et al. |
Circulating oncometabolite 2-hydroxyglutarate is a potential surrogate biomarker in patients with isocitrate dehydrogenase-mutant intrahepatic cholangiocarcinoma. |
2014 |
Clin. Cancer Res. |
pmid:24478380
|
Işıkay S et al. |
A child with L-2 hydroxyglutaric aciduria presenting with dilated cardiomyopathy: coincidence or a new syndrome? |
2014 |
Anadolu Kardiyol Derg |
pmid:24382499
|
Terunuma A et al. |
MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis. |
2014 |
J. Clin. Invest. |
pmid:24316975
|
Gilbert MR et al. |
Autophagy and oxidative stress in gliomas with IDH1 mutations. |
2014 |
Acta Neuropathol. |
pmid:24150401
|
Navis AC et al. |
Increased mitochondrial activity in a novel IDH1-R132H mutant human oligodendroglioma xenograft model: in situ detection of 2-HG and α-KG. |
2013 |
Acta Neuropathol Commun |
pmid:24252742
|
Wang JH et al. |
Prognostic significance of 2-hydroxyglutarate levels in acute myeloid leukemia in China. |
2013 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:24082129
|
Lu C et al. |
Induction of sarcomas by mutant IDH2. |
2013 |
Genes Dev. |
pmid:24065766
|
Chaumeil MM et al. |
Non-invasive in vivo assessment of IDH1 mutational status in glioma. |
2013 |
Nat Commun |
pmid:24019001
|
McKenney AS and Levine RL |
Isocitrate dehydrogenase mutations in leukemia. |
2013 |
J. Clin. Invest. |
pmid:23999441
|
Andronesi OC et al. |
Detection of oncogenic IDH1 mutations using magnetic resonance spectroscopy of 2-hydroxyglutarate. |
2013 |
J. Clin. Invest. |
pmid:23999439
|
Guilhamon P et al. |
Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2. |
2013 |
Nat Commun |
pmid:23863747
|
Cairns RA and Mak TW |
Oncogenic isocitrate dehydrogenase mutations: mechanisms, models, and clinical opportunities. |
2013 |
Cancer Discov |
pmid:23796461
|
DiNardo CD et al. |
Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemia. |
2013 |
Blood |
pmid:23641016
|
Losman JA and Kaelin WG |
What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer. |
2013 |
Genes Dev. |
pmid:23630074
|
Ward PS et al. |
The potential for isocitrate dehydrogenase mutations to produce 2-hydroxyglutarate depends on allele specificity and subcellular compartmentalization. |
2013 |
J. Biol. Chem. |
pmid:23264629
|
Jin G et al. |
Disruption of wild-type IDH1 suppresses D-2-hydroxyglutarate production in IDH1-mutated gliomas. |
2013 |
Cancer Res. |
pmid:23204232
|
Pollyea DA et al. |
2-Hydroxyglutarate in IDH mutant acute myeloid leukemia: predicting patient responses, minimal residual disease and correlations with methylcytosine and hydroxymethylcytosine levels. |
2013 |
Leuk. Lymphoma |
pmid:22680765
|